Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against AstraZeneca plc
Robbins Geller Rudman & Dowd LLP ( https://www.rgrdlaw.com/cases-astrazenecaplc-class-action-lawsuit.html ) today announced that it filed a class action on behalf of an institutional investor seeking to represent purchasers of AstraZeneca plc (NASDAQ:AZN) American Depositary Shares (ADSs) between May 21, 2020 and November 20, 2020, inclusive (the Class Period).
- Robbins Geller Rudman & Dowd LLP ( https://www.rgrdlaw.com/cases-astrazenecaplc-class-action-lawsuit.html ) today announced that it filed a class action on behalf of an institutional investor seeking to represent purchasers of AstraZeneca plc (NASDAQ:AZN) American Depositary Shares (ADSs) between May 21, 2020 and November 20, 2020, inclusive (the Class Period).
- A lead plaintiff acts on behalf of all other class members in directing the AstraZeneca class action lawsuit.
- The lead plaintiff can select a law firm of its choice to litigate the AstraZeneca class action lawsuit.
- Robbins Geller Rudman & Dowd LLP is one of the worlds leading law firms representing investors in securities litigation.